Stakeholder Perspectives in Men's Health August 2014
As the US healthcare system continues to evolve, physicians in every state and specialty are attempting to comply with new rules, expectations, and costs, and must adapt to meet new healthcare demands.
XIAFLEX (collagenase clostridium histolyticum): A New Option for the Treatment of Peyronie’s Disease
Collagenase clostridium histolyticum (CCH), a purified mixture of 2 microbial collagenases, is a minimally invasive intervention recently approved by the FDA for the treatment of PD, under the brand name XIAFLEX.
Results 1 - 2 of 2